Meet our team
In order to accelerate oncology innovation and asset commercialisation we have built a team of experts who have not only successfully achieved this in their careers to date but who are committed to contributing their experience and expertise to continued innovation and success in oncology drug development both now and in the future
The cross-functional team at Cumulus are individually and collectively exceptional scientists and entrepreneurs in the oncology area, many with successful drug development programmes to their name. This blend of scientific acumen, commercial understanding coupled with proven operational ability blends powerfully with the shared purpose of the team; to innovate in oncology drug discovery and development to ensure that only the most promising scientific discoveries are translated into new therapeutic options for cancer patients.
Board of Directors
Dr Russell Greig
Chairman
Extensive biotech & VC investment experience
Dr Clare Wareing
Founder & CEO
Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.
Dr Sally Waterman
NED
Entrepreneur and biotech industry veteran with extensive drug development, commercialisation and board experience. Company builder.
Dr Diane Seimetz
NED
Entrepreneur and expert in the development and commercialisation of biologics. Company builder.
Dr Andrew McNeill PhD
Investor Director
Serial entrepreneur and investor in the technology and life sciences sector. Expertise in company spin-outs, deal structure, investment and exit strategies. Company builder.
Mr Keith Murdoch
NED
Entrepreneur and investment strategist. Expertise in deal negotiation and M&A activities as well as investor relations, financial modelling and business management.
Clare Doris
Chief Operating Officer
A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.
Cumulus Core Team
Dr Clare Wareing
Founder & CEO
Senior Executive and entrepreneur with the vision, drive and experience of successful oncology drug development and company exits to lead the company forward. Company builder.
Clare Doris
Chief Operating Officer
A life sciences entrepreneur with a successful career in building and managing companies in the sector. Clare plays a key role in Cumulus’ ambitious growth plans.
Dr Ian Waddell
Chief Scientific Officer
Oncology focussed biochemist with more than 25 years’ experience and a proven track record of drug discovery in a variety of settings including large pharma, academic and CRO. Has interests in target identification / validation and synthetic lethal and epigenetics.
James Fair
Chief Financial Officer
A seasoned financial executive with a strong track record in driving financial strategies and operational excellence. Proven ability to navigate complex financial landscapes and deliver strategic solutions sets him apart as a trusted leader in the industry.
Scott Doak
Group Finance Director
Entrepreneurial financial strategist with extensive experience of financial modelling and business management, deal negotiation and investor relations.
Dominic James
Executive in Residence
With over 30 years of experience in drug discovery and molecular biology. As a seasoned CRO team leader, scientific consultant and freelance editor, Dominic offers valuable expertise in oncology.
Thomas Wirth
Executive in Residence
Expertise in cell and gene therapy, combined with significant contributions to regulatory compliance, product development, fundraising, and operational efficiency. Proven track record in revenue generation and relationship building, establishing valuable partnerships within the industry.
Tim Sparey
Business Strategy Specialist
Highly motivated with 22 years of experience in blue chip big pharma, specialty pharma, and biotech. Held CEO and business development positions in companies focused on neuroscience, cancer, diabetes, and ophthalmology. Notable achievements include founding start-ups, fundraising, and major partnerships with Lundbeck and GSK. A strategic leader driving innovation and success in the biopharma industry.
Dr Nikki March
Senior Director of Scientific Affairs
Highly skilled scientist, with over 20 years’ experience in the oncology area, spanning molecular signalling, signal transduction pathways and applications in drug discovery.
Manuelle Debunne PhD
Director of Scientific Affairs
Entrepreneurial scientist with proven ability to manage academic and industry programs to translate oncology assets towards clinical development.
Dr Isabel Dodd
Director of Business Development
A seasoned life sciences professional with extensive experience in drug development, ranging from early-stage research to clinical trials and manufacturing. She has worked across academia, start-ups, and large corporations. With three years of experience as a life science investor, Isabel brings a unique perspective to driving our business development initiatives.
Daragh Campbell
Project Manager
Entrepreneurial scientist with industrial management experience to support executive and commercial teams.
Arlene Davie
Admin
Experienced Office Manager with a demonstrated history of working in the biotechnology industry. Strong administrative professional with over 30 years experience.
Scientific Advisory Board
Consultants
We are hiring
Want to be part of a mission-led company in oncology drug development?
